You are on page 1of 8

Take a closer look

at protection
RonaCare® CPC and
RonaCare® Cetrimonium Bromide
Fine-tune Your Formulations
Merck’s effective, dual-functional antimicrobial protection
Artists pay close attention when they mix their paints since it may not take much pigment to create
the right color. The same applies to antimicrobial substances – they too are effective at low levels.
Thus even a small amount is highly beneficial for the protection against mircoorganisms – a must
in our modern life since they can affect the consumer negatively in several ways.

The appropriate use of preservatives or antimi-


crobials highly influences the development of
new and innovative products. The preservatives
and antimicrobials must support a long life
cycle for the product plus give maximum pro-
tection to the skin, enabling a minimal forma-
tion of odor, for example sweat or bad mouth/
breath odor. Merck offers two outstanding prod-
ucts to com­­bat mircoorganisms: RonaCare® CPC
and RonaCare® Cetrimonium Bromide. They
represent quaternary ammonium salts (quats,
amphoteric surface active substances) with ap-
The importance of protective measures becomes proved antimicrobial and fungicidal effects and
evident when one bears in mind that even the additional spectrum of action, for example anti-
air around us contains innumerable microbes, static properties.
both harmless and pathogenic, all of which at-
tempt to settle on a suitable nutrient – namely
the skin or an opened cosmetic product – in Literature
order to develop or reproduce.
1. C.R. Birnie, et al., “Antimicrobial evaluation of N-alkyl
Depending on the site of action, an ingredient betains and N-alkyl-N, N-dimethylamine oxides with
is called an “antimicrobial” if you focus on skin variations in chain length,” Antimicrob. Agents
protection and a “preservative” when you want Chemother. 44 (2000): 2514–2517.
to protect a product. In both cases, the objective 2. S.B. Lee, et al., “Permanent, nonleaching antibacterial
is to inhibit the growth of microorganisms. surfaces. 1. Synthesis by atom transfer radical polym-
erization. Biomacromolecules 5 (2004): 877–882.
Regulatory Affairs
The use of RonaCare® CPC and RonaCare® Cetrimonium Bromide preservatives is illustrated in the
table below. The utilization of active ingredients in the EU is under the responsibility of the Cosmet-
ics Regulation (EC) 1223/2009 which gives a clear definition regarding preservatives. The use of skin
antimicrobials as active ingredients is under the responsibility of the manufacturer in many countries
such as the EU. However, the USA and Japan have established further stringent regulations which
must be taken into account. The final decision in using active ingredients in cosmetic products listed
in the table below is the responsibility of our customers, considering all relevant regulations.

Preservative Antimicrobial Use Other


EU USA JAPAN EU USA JAPAN
EU/USA/JAPAN
Positive List: Not specifically “Standards for Not specifically OTC drug Quasi-drug
Annex V regulated Cosmetics regulated
Regulation (EC) (Notification
1223/2009 No. 331 of
2000)”
If CPC is used in a cosmetic
OTC drug, product or in a product other
RonaCare® Category I, than drug use, e.g. as an emulsi-
CPC l l l(1) l Oral care l(3) fier, a wetting agent or as an
ingredients(2) anti-static agent, it is classified
as a cosmetic ingredient.
If cetrimonium bromide is used
in a cosmetic product or in a
RonaCare® product other than drug use,
Cetrimonium l l l l l l(3) e.g. as an emulsifier, a wetting
agent or as an anti-static agent,
Bromide
it is classified as a cosmetic
ingredient.

l Use permitted l Use not permitted



(1) Restrictions in three categories: permitted as preservative according to the “Standards for Cosmetics (Ministry of
Health and Welfare Notification No. 331 of 2000)”
Category 1 - Cosmetics which are not applied on mucous membranes and are washed away immediately after
application: maximum concentration 5.0 g /100 g
Category 2 - Cosmetics which are not applied on mucous membranes and are not washed away immediately
after application: maximum concentration1.0 g /100 g
Category 3 - Cosmetics which are applied on mucous membranes: maximum concentration 0.01 g /100 g
(2) Proposed rule
(3) Japan Pharmaceutical Affair Law Notification 990 (September 29, 2000)

Literature
“Preservative regulations: a global overview,” Personal
Care Magazine, January 2009: 67–73.
RonaCare® CPC
Make it part of your complete oral care package
Hair care products
RonaCare® CPC can be used in shampoos for the
symptomatic treatment of dandruff. Moreover,
hair becomes soft and silky when treated with it
– an ideal component for hair styling products.
The agent imparts sheen and anti-static proper-
ties to hair, making it appropriate for hairsprays,
setting lotions, hair colorants and as a supple-
ment to cold-wave preparations.

Skin care products


Its wide spectrum of performance such as sub-
stantivity on skin and hair, foaming, emulsifying
and antimicrobial properties make RonaCare®
CPC suitable for other products, for example
deodorants and antiperspirants. It also can be
The active ingredient in RonaCare® CPC is used in shaving lotions or wet wipes.
cetylpyridinium chloride, a cationic wetting and/
or surface-active agent, similar to soap, that has
bactericidal properties. RonaCare® CPC is very Technical Data
effective in the following applications.
INCI Name Cetylpyridinium Chloride
Oral care products Appearance White powder
RonaCare® CPC is effective in preventing dental Solubility Water: 8 g/100 ml (20 °C)
plaque, protecting against tooth decay and Ethanol: 30 g/100 ml
reducing gingivitis. Owing to its surface activity Stability Stable under standard conditions
or wetting properties, it is especially effective in
reaching wrinkles and pockets of mucous in the
mouth. The bacteria-filled phlegm of the mucous Applications
membrane is removed, even in areas that are
difficult to access. It is effective in mouthwashes • Oral care: use level 0.05–0.1%
and sprays. With products such as fluorine • Hair care: use level 0.1–1.0%
sources RonaCare® NaF and RonaCare® Olaflur • Skin care: use level 0.05–0.5%
or with RonaCare® Calcium Carbonate, made
epecially suitable for dental care, RonaCare®
CPC can offer beneficial aspects for after- For Your Information
treatment applications. It supplements the
oral care package. • pH optimum for efficacy: 4–10
• The bactericidal effect is reduced by the pres-
ence of anionic-active substances, salicyclic
acid, talc, kaolin and polyphosphates owing
to the formation of insoluble precipitates.
• Incompatible with a number of high-molecu-
Ordering Information lar compounds commonly used as thickening
Item No. Name Package Size agents including carboxymethyl cellulose,
alginates, gelatin and tragacanth.
102340 RonaCare® CPC 2.5 kg, 25 kg, 100 g sample
Spectrum of Activity
RonaCare® CPC protects against gram-positive Fungicidal Activity of RonaCare® CPC
and gram-negative bacteria as well as fungicidal Killing times for a concentration of 1:100 at 22 °C
attacks. It therefore offers a broad spectrum to Trichophyton mentagrophytes < 24 hours
protect skin and products. Candida albicans < 24 hours
Aspergillus fumigatus < 24 hours
Microsporum audouini < 24 hours
Classification of bacteria Histoplasma capsulatum < 24 hours

The classification of bacteria is based on a bac-


terial staining method developed by the Danish
doctor Gram in 1884. This staining method
allows a clear color-based classification. Gram- Bactericidal* Activity of RonaCare® CPC
positive bacteria retain a violet color. Families Killing times for concentrations ranging from
of gram-positive bacteria are: micrococci, strep- 1 : 10,000 to 1 : 100,000 at 22 °C
tococci, staphylococci, corynebacteria, lactobac- Gram-positive bacteria
teria and bacilli. Gram-negative bacteria, on the Staphylococcus aureus 2 min.
Streptococcus pyogenes
other hand, retain a red color. Families of gram-
Gram-negative bacteria
negative bacteria are: Neisseria family, nitrobac- Escherichia coli
teria, azotobacteria, rhizobiacea, psoedomonas 2 min.
Pseudomonas aeruginosa
family and enterobacteria. Proteus vulgaris

Literature
1. A. Bosy, “A review of oral products for the treatment of 7. Y. Pomeranz, “Inactivation of a-amylase by synthetic
mouth odor,” ADHA InTouch, (2004): 4–6. detergents,” Biochem. Biophys. Acta Vol. 73 (1963): 105;
2. O. G. Clausen, “An examination of the bacteriostatic and ref. Chem. Abstr. 59, 14382e (1963).
bactericidal, fungistatic and fungicidal effects of cetyl- 8. E. L. Prince, et al., “The efficacy of cetylpyridinium chlo-
pyridinium chloride and 2-bromo-2-nitropropan-1,3-di- ride glove coatings against staphylococcus epidermidis
ol, separately and in combinations also including benzyl and staphylococcus aureus,” International Biodeteriora-
alcohol,” Pharm. Ind. Vol. 35 No. 11 (1973): 726–729. tion & Biodegradation Vol. 39, No. I (1997): l-7.
3. O. G. Clausen, “An examination of the bactericidal and 9. P. Renton-Harper, et al., “A comparison of chlorhexi-
fungistatic effects of cetylpyridinium chloride, sepa- dine, cetylpyridinium chloride, triclosan, and C31G
rately and in combinations embodying EDTA and benzyl mouthrinse products for plaque inhibition,” Journal of
alcohol,” Pharm. Ind. Vol. 35 No. 12 (1973): 869–874. Periodontology Vol. 67, No. 1 (1996): 486–489.
4. Jan-Frederik Güth, Klinische Studie zur “Untersu­ 10. A. R. Volpe, et al., “Antimicrobial control of bacterial
chung der Effektivität zweier Mundspüllösungen mit plaque and calculus and the effects of these agents on
antibakteriellen Wirkstoffen bei der Bekämpfung und oral flora,” Journal of Dental Research Vol. 48 (1969):
Entstehung von Mundgeruch,” 2008. 832.
5. S. Jenkins, et al., “A comparison of cetylpyridinium chlo- 11. G. Welter, et al., “Cetylpyridinium reduziert Zahn-
ride, triclosan and chlohexidine mouthrinse formula- plaques,” Deutsche Apotheker Zeitung Vol. 123, No. 9
tions for effects on plaque regrowth,” Journal of Clinical (1983): 421–422.
Periodontology Vol. 21 (1994): 441-444. 12. B. Zdralek, “Quarternäre Ammoniumverbindungen in
6. N. N., “Quaternäre Ammoniumverbindungen in der der Kosmetik,” Seifen-Öle-Fette-Wachse Vol. 84 (1958):
Kosmetik,” Österreichische Apotheker-Zeitung Vol. 17 697.
(1963): 386.
RonaCare® Cetrimonium Bromide
Formulate safe, effective, long-lasting hygiene products

Technical Data
INCI Name Cetrimonium Bromide
Appearance White powder
Solubility Water: 0.3 g/100 ml (20 °C)
0.2 g/100 ml (25 °C)
Ethanol: 18 g/100 ml
Stability Stable under standard conditions

Applications
• Hair care: use level 0.1–1.0%
• Skin care: use level 0.5–1.0%

The active ingredient in RonaCare® Cetrimonium


Bromide is cetyltrimethylammonium bromide For Your Information
and has proven to be very effective in the fol-
lowing applications. • pH optimum for efficacy: 4–10
• Being a cationic surfactant, cetrimonium bro-
Hair care products mide is liable to foam in aqueous solutions
Owing to its fungicidal and bactericidal actions, and is incompatible with anionic surface-
RonaCare® Cetrimonium Bromide is used as an active agents as well as peptides, polymer
anti-dandruff additive in shampoos and hair lo- phosphates and zinc salts.
tions. Since it makes hair glossy and more man- • Cetrimonium bromide is also incompatible
ageable, it is also incorporated into conditioners, with alkalis, proteins and a number of high-
setting lotions, hair rinses, hair styling products molecular compounds commonly used as
and hair colorants. thickening agents such as agar-agar, car-
boxymethylcellulose, alginates, gelatin and
Skin care products tragacanth.
RonaCare® Cetrimonium Bromide is formulated
into a wide range of skin care products including
deodorant, where it assists in preventing unpleas-
ant body odor which results from microbial de-
composition of perspiration, to bath and shower
products. Its ability to control and kill bacteria
and protect skin makes it appropriate for shav-
ing creams, aftershaves, acne treatments, face
cleansers, face creams, exfoliating gels, hygiene
products such as wet wipes and much more.

Ordering Information
Item No. Name Package Size
102343 RonaCare® Cetrimonium Bromide 1 kg, 25 kg 100 g sample
Spectrum of Activity
RonaCare® Cetrimonium Bromide has shown effects also have been achieved for some test
good bacteriostatic and bactericidal action strains where its fungicidal activity was found to
against a number of gram-positive and gram- be superior to that of other quaternary ammo-
negative germs in various tests. Good fungicidal nium salts.

Fungicidal Activity of RonaCare® Cetrimonium Bromide


Killing times for various concentrations; Temperature 22 °C
Concentration 1 : 100 1 : 200 1 : 1,000 1 : 2,000 1 : 10,000
Trichophyton mentagrophytes 10 min. 4 hours 4 hours 4 hours 24 hours
Candida albicans 24 hours
Aspergillus fumigatus 24 hours
Microsporum audouini 10 min. 10 min. 30 min. 30 min. 1 hour
Histoplasma capsulatum 10 min. 24 hours

Bacterial Activity of RonaCare® Cetrimonium Bromide


Killing times for various concentrations; Temperature 22 °C
Concentration 1 : 10,000 1 : 20,000 1 : 40,000 1 : 100,000
Escherichia coli 2 min. 2 min. 2 min. 30 min.
Pseudomonas aeruginosa 2 min. 2 min. 2 min. 5 min.
Staphylococcus aureus 5 min. 5 min. 5 min. 5 min.
Streptococcus pyogenes 2 min. 2 min. 2 min. 2 min.
Proteus vulgaris 2 min. 2 min. 2 min. 5 min.

Literature
1. P. Benigno and T. Berti, “Antibacterial action of cetyl- 7. E. S. Lambert, “Kationaktive Verbindungen als Zusätze
trimethylammoniumbromide of escherichia coli: effect zu Kosmetika,” Kosmetik-Parfüm-Drogen-Rundschau
of short contact,” Arch. intern. pharmacodyn. Vol 93 Vol. 10 (1963): 141.
(1953): 412; ref. Chem Abstr. 48, 9459b (1954). 8. N. N., “Quarternäre Ammoniumverbindungen in der
2. Ch. M. Cousins, “Bacteriological screening test for Kosmetik,” Österr. Apotheker-Zeitung 17 (1963): 24,
quarternary ammonium compounds and formulations,” 386.
Proc. Soc. Appl. Bacteriol. Vol. 14 (1951): 184; ref. 9. G. Nicoletti, et al., “The antimicrobial activity in
Chem. Abstr. 49, 5779d (1955). vitro of chlorhexidine, a mixture of isothiazolinones
3. R. Frank and G. Stark, “Über die antibakterielle (‘Kathon’ CG) and cetyl trimethyl ammonium bromide
Wirkung von Acriflavin und Cetyltrimethylammonium- (CTAB),” Journal of Hospital Infection Vol. 23 No. 2
bromid in versch. Salbengrundlagen,” Pharm. Acta Helv. (1993): 87–111.
Vol. 29 (1954): 81. 10. A. Obayashi, “Action of surface active agents on mi-
4. J. C. Hoogerheide, “The germicidal properties of certain croorganisms. The germicidal action and the effect on
quarternary ammonium salts with special reference permeability,” Nippon Nogeikagaku Kaishi 35 (1961):
to cetyltrimethylammoniumbromide,” J. Bact. Vol. 49 61; ref. Chem. Abstr. 60, 11093e (1964).
(1945): 277; ref. Chem. Abstr. 39, 28467 (1945). 11. W. Paulus, Ed., Directory of microbicides for the protec-
5. J. S. Jellinek, Kosmetologie (Heidelberg: Dr. Alfred tion of materials (Springer, 2005): 708.
Hüthig Verlag, 1959): 78, 267. 12. H. H. Rodin, “Treatment of primary and secondary
6. A. Kluge, “Die Eigenschaften quartärer Ammonium- infections of the skin with cetyltrimethylammonium-
salze und ihre Verwendung in kosmetischen Mitteln bromide,” J. pharm. Sci. 51 (1962): 1107.
zur Behandlung der Haare,” Parfümerie und Kosmetik
42 (1961): 341.
MERCK provides information on application technologies and relevant regulations based upon our current knowledge
and opinion at the time of printing. MERCK makes no representation or warranty of any kind, express or implied,
including merchantability or fitness for a particular use, with respect to such information or its application. Purchasers
must independently determine the suitability of our ingredients for the purchaser’s intended product, use or process.
Purchaser is responsible for observing all laws and regulations relevant to such products, uses or processes. The fore­
going information and suggestions are also provided without warranty of non-infringement as to the intellectual prop-
erty rights of third parties, and shall not be construed as any inducement to infringe the rights of third parties.

Release date: December 2011


For more information Asia
please contact: Cosmetic Customer Service Center
Merck Ltd. – Taiwan
Europe 6F, No. 89, Sec. 2
Merck KGaA Ti-Ding Blvd.
64271 Darmstadt Taipei 11493
Germany Taiwan
Phone: +49 6151 72-7774 Phone: +886 2 2162-1111 ext. 1640
Fax: +49 6151 72-3110 Fax: +886 2 8751-1515
e-mail: cosmetic@merckgroup.com e-mail: Corry.Chen@merckgroup.com
www.merck4cosmetics.com www.merck4cosmetics.com
W500191

The United States & Canada Japan


EMD Chemicals Merck Ltd.
Performance Materials Division ARCO Tower, 5 F
One International Plaza 8-1, Shimomeguro 1-chome
Suite 300 Meguro ku
Philadelphia, PA 19113 Tokyo 153
USA Japan
Phone: +1 484 652-5600 Phone: +81 3 5434-4711
Fax: +1 484 652-5749 Fax: +81 3 5434-4704
e-mail: rona@merckgroup.com e-mail: merck_cos@merck.co.jp
www.emdchemicals.com www.merck4cosmetics.com

You might also like